News

Webcast Image Webcast
Q2 2020 IRIDEX Earnings Conference Call
08/06/20 at 5:00 PM EDT

Date Title Teaser
08/06/20
Summary ToggleIRIDEX Announces Second Quarter 2020 Financial Results MOUNTAIN VIEW, Calif. , Aug. 06, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ended June 27, 2020 . Second Quarter Summary Total revenue declined 40% to $6.2 million versus $10.4 million in the prior year period Cost control
07/23/20
Summary ToggleIRIDEX to Report Second Quarter 2020 Financial Results on August 6, 2020 MOUNTAIN VIEW, Calif. , July 23, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter of 2020 after the close of trading on Thursday, August 6, 2020 .  The Company’s management team will host a corresponding
05/11/20
Summary ToggleIRIDEX Announces First Quarter 2020 Financial Results MOUNTAIN VIEW, Calif. , May 11, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended March 28, 2020 . Commenting on the recently completed quarter and the business environment created by the COVID-19 pandemic, David I.
04/28/20
Summary ToggleIRIDEX to Report First Quarter 2020 Financial Results on May 11, 2020 MOUNTAIN VIEW, Calif. , April 28, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the first quarter of 2020 after the close of trading on Monday, May 11, 2020 . The Company’s management team will host a corresponding
04/21/20
Summary ToggleIRIDEX Announces the Appointment of Doris Engibous to its Board of Directors MOUNTAIN VIEW, Calif. , April 21, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the appointment of Doris Engibous to its board of directors effective
03/30/20
Summary ToggleIRIDEX ANNOUNCES RETIREMENT OF VP FINANCE Names Prior CFO/COO as Interim CFO MOUNTAIN VIEW, Calif. , March 30, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that Romeo Dizon has retired from his
03/12/20
Summary ToggleIRIDEX Announces Fourth Quarter and Full Year 2019 Financial Results MOUNTAIN VIEW, Calif. , March 12, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter ended December 28, 2019 . Fourth Quarter Highlights Cyclo G6® product family revenue grew 18% year-over-year to $3.7 million , or 31% of total revenue
02/28/20
Summary ToggleIRIDEX to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020 MOUNTAIN VIEW, Calif. , Feb. 28, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the fourth quarter and full year of 2019 after the close of trading on Thursday, March 12, 2020 .  The Company’s management team will host a
02/26/20
Summary ToggleIRIDEX Launches Revised MicroPulse P3® Device for Glaucoma MOUNTAIN VIEW, Calif. , Feb. 26, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today the introduction of the second generation of the MicroPulse P3 ® Device,
01/13/20
Summary ToggleIRIDEX Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2019 MOUNTAIN VIEW, Calif. , Jan. 13, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary operational and financial results for the fourth quarter and full year ended December 28, 2019 . Highlights Total revenue for the fourth quarter of 2019 expected to be $11.6 -
logo aa0 logo ags logo ascrs logo asrs logo esrs0 logo euretina